Ketamine-associated bladder dysfunction: Original Article

International Journal of Urology

Volumn 16, Issue 10, 2009, Pages 826-829

  Tsai, Tsung Hsun ^a   Cha, Tai Lung ^a   Lin, Chang Min ^a   Tsao, Chih Wei ^a   Tang, Shou Hung ^a   Chuang, Feng Pin ^a   Wu, Sheng Tang ^a   Sun, Guang Huan ^a   Yu, Dah Shyong ^a   Chang, Sun Yran ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Bladder instillation; Cystitis; Hyaluronic acid; Ketamine

Indexed keywords

HYALURONIC ACID; KETAMINE;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; URINALYSIS; URINE CULTURE; URODYNAMICS;

ADULT; FEMALE; HUMANS; KETAMINE; MALE; SUBSTANCE-RELATED DISORDERS; URINARY BLADDER DISEASES; YOUNG ADULT;

EID: 70349737904     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02361.x     Document Type: Article

References (15)

1. Vroegop MP, van Dongen RT, Vantroyen B, Kramers C Ketamine as a party drug Ned. Tijdschr. Geneeskd. 2007 151 : 2039 2042 In Dutch).
2. Ricaurte GA, McCann UD. Recognition and management of complications of new recreational drug use. Lancet 2005 365 : 2137 2145.
3. Akporehwe NA, Wilkinson PR, Quibell R, Akporehwe KA. Ketamine: a misunderstood analgesic? BMJ 2006 332 : 1466.
4. Trujillo KA, Zamora JJ, Warmoth KP. Increased response to ketamine following treatment at long intervals: implications for intermittent use. Biol. Psychiatry 2008 63 : 178 183.
5. Craven R. Ketamine. Anaesthesia 2007 62 (Suppl 1 48 53.
6. Adamowicz P, Kala M. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J. Anal. Toxicol. 2005 29 : 376 382.
7. Agarwal A, Gupta D, Kumar M, Dhiraaj S, Tandon M, Singh PK. Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br. J. Anaesth. 2006 96 : 587 589.
8. Chu PS, Kwok SC, Lam KM et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med. J. 2007 13 : 311 313.
9. Chu PS, Ma WK, Wong SC et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008 102 : 1616 1622.
10. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2008 19 : 717 721.
11. Shahani R, Streutker C, Dickson B, Stewart RJ. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 2007 69 : 810 812.
12. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections and hemorrhagic cystitis? Eur. Urol. 2007 51 : 1534 1540 discussion 1540 1541.
13. Kallestrup EB, Jorgensen SS, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand. J. Urol. Nephrol. 2005 39 : 143 147.
14. Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pflüger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur. Urol. 2005 47 : 393 397.
15. Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. 2008 95 : 219 229.